Cargando…

516. Evaluation of COVID-19 Monoclonal Antibody Therapies for the Treatment of Non-hospitalized Patients with COVID-19

BACKGROUND: In an effort to reduce strain on healthcare systems with patient hospitalizations and deaths due to COVID-19, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for 2 monoclonal antibodies for the treatment of COVID-19 in November 2020: bamlanivimab (BA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morado, Faiza, Nanda, Neha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643880/ http://dx.doi.org/10.1093/ofid/ofab466.715

Ejemplares similares

1257. The Impact of Communication Type on Acceptance Rates of Antimicrobial Stewardship Interventions
por: Morado, Faiza, et al.
Publicado: (2023)

549. Monoclonal Antibody Therapy for COVID-19 Infection in Michigan: The Flint Experience
por: Younas, Mariam, et al.
Publicado: (2021)

936. Antimicrobial Stewardship Assessments in De-labeling Beta-lactam Allergies
por: Fahmy, Nicole, et al.
Publicado: (2022)

558. Implementation and Outcomes of a COVID-19 Monoclonal Antibody Treatment Program in an Urban Safety-net Community Hospital
por: Mena Lora, Alfredo J, et al.
Publicado: (2021)

516. A Systematic Literature Review Evaluating Real-World Use of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Death
por: Cha-Silva, Ashley S, et al.
Publicado: (2023)

953. Online Medical Education Improves Knowledge of Monoclonal Antibody Treatment for COVID-19 Among Physicians
por: Armagan, Allison, et al.
Publicado: (2021)

526. Implementation of Use of Monoclonal Antibody Therapy in a Large Academic Center for the Outpatient Treatment of Covid-19: Impact on 30 Day Hospitalization Rates, ED Visits and Death
por: Bhimani, Azra, et al.
Publicado: (2021)

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience
por: Sannareddy, Aishwarya, et al.
Publicado: (2022)

501. Implementation and Outcomes of a Program to Coordinate and Administer Monoclonal Antibody Therapy to Long-Term Care Facility Residents with COVID-19
por: Watkins, Andrew B, et al.
Publicado: (2021)

522. Evaluation of Three COVID-19 Monoclonal Antibody Regimens in the Context of Rising B.1.526 Prevalence in New York City
por: Bao, Hongkai, et al.
Publicado: (2021)

Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure
por: Minoia, Carla, et al.
Publicado: (2022)

537. Implementation of a Workflow for COVID-19 Monoclonal Antibody Infusions at a Veterans Affairs Medical Center
por: Patel, Pratish C, et al.
Publicado: (2021)

546. COVID-19 Monoclonal Antibody Use at a Stand Alone Children’s Hospital
por: Stimes, Grant T, et al.
Publicado: (2023)

514. Anti-SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real World Experience
por: Belden, Katherine, et al.
Publicado: (2021)

Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2022)

512. Does Time From COVID-19 Symptom Onset to Administration of Anti-spike Protein Monoclonal Antibody Predict Response?
por: SanFilippo, Savanna, et al.
Publicado: (2021)

516. SARS-CoV-2 Exhibits Clade-specific Differences in Nasopharyngeal Viral Loads
por: Nam, Hannah, et al.
Publicado: (2020)

31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19
por: Lim, C., et al.
Publicado: (2021)

544. Using Active Surveillance to Identify Monoclonal Antibody Candidates Among COVID-19 Positive Veterans, Atlanta VA Healthcare System
por: Paras, Alexander T, et al.
Publicado: (2021)

556. Evaluation of Hydroxychloroquine-based Combination Therapies for the Treatment of COVID-19
por: Berti, Andrew David, et al.
Publicado: (2020)

39. Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19
por: Hardesty, Anna, et al.
Publicado: (2021)

Evaluation of neonatal outcomes in COVID-19 positive mothers who received monoclonal antibodies
por: Chen, Katherine, et al.
Publicado: (2023)

Evaluation of allergic reactions from different monoclonal antibodies used for COVID-19 in pregnancy
por: Chen, Katherine, et al.
Publicado: (2023)

417. COVID-19 Aerostudy: Evaluation of SARS-CoV-2 Virus in the Air of Patients Hospitalized with COVID-19
por: Hamza, Hamed, et al.
Publicado: (2021)

516. Implementation of a Probiotic for the Primary Prevention of Hospital-Onset Clostridium difficile Infection
por: Shihadeh, Kati, et al.
Publicado: (2018)

1148. Relationship Between the Duration of Symptoms Before and COVID-19 Disease Outcome After Monoclonal Antibody Therapy
por: Hubbard, Michael J, et al.
Publicado: (2022)

535. Risk Factors for Seeking Medical Care Following Monoclonal Antibody Treatment For COVID-19
por: MALIK, I S M A I L O, et al.
Publicado: (2023)

51.6 IMPACT OF COVID-19 ON THE GLOBAL ASSESSMENT OF FUNCTIONING SCORES
por: Prakash, Meeta, et al.
Publicado: (2020)

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination
por: Zanwar, Saurabh, et al.
Publicado: (2022)

473. Clinical Outcomes of a Pediatric COVID Monoclonal Antibody Program based at an Urban Academic Center
por: Lee, Philip J, et al.
Publicado: (2021)

1402. Expand accessibility of monoclonal antibody in COVID-19 among different ethnicities and races.
por: Farooq, Hina, et al.
Publicado: (2022)

P14 Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study
por: Euden, Joanne, et al.
Publicado: (2022)

Monoclonal antibodies as treatment for COVID-19
por: Medina Gamero, A., et al.
Publicado: (2022)

554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection
por: Mann, Inderjit, et al.
Publicado: (2021)

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2022)

330. Evaluating the Relationship Between Comorbidity Treatment Status and In-hospital Mortality Among COVID-19 Patients
por: Davenport, Cristy, et al.
Publicado: (2021)

Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy
por: El Sharaiha, Rand, et al.
Publicado: (2023)

189. Bacteremia among COVID-19 and Non-Covid-19 Patients Admitted in the ICU
por: chra, paraskeui, et al.
Publicado: (2021)

771. COVID-19 on the Line: A Significant Increase in CLABSI in Hospitalized Patients with COVID-19 at a Major Teaching Hospital
por: Haroun, Pishoy, et al.
Publicado: (2021)

291. Epidemiology of Candidemia Rates during COVID-19 and Comparison of Outcomes in Candidemia Between COVID-19 and Non-COVID-19 Patients
por: Cruz, Angela Beatriz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_afn78utpkunqt1pkvh8jui5th9